Condition

Sclerosis

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting1

Common interventions9

Lead sponsors shown5

Clinical trials

5 shown

Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple SclerosisNCT06201026 · 2023-09-12

RECRUITING

Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple SclerosisNCT04786821 · 2022-06-23

COMPLETED

Aerobic Exercise for Remyelination in Multiple SclerosisNCT04539002 · 2021-04-29

COMPLETED

Power Training in Older Multiple Sclerosis PatientsNCT04762342 · 2020-12-07

UNKNOWN

Assessment of Language Disorders in Multiple Sclerosis PatientsNCT04465084 · 2020-08-17

COMPLETED

Common interventions

Aerobic exerciseBEHAVIORAL1 CaseOTHER1 Education Group ControlBEHAVIORAL1 Individualized exerciseOTHER1 Phoenix Exoskeleton suitDEVICE1 Power trainingOTHER1 Standard Exercise TrainingBEHAVIORAL1 Traditional exerciseOTHER1 WithnessOTHER1

Leading sponsors

Centre Hospitalier Universitaire de Saint Etienne 1 Fondation Ophtalmologique Adolphe de Rothschild 1 Oregon Health and Science University 1 Sheffield Teaching Hospitals NHS Foundation Trust 1 University of Aarhus 1

Trial status mix

COMPLETED3

RECRUITING1

UNKNOWN1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.